Status:

COMPLETED

Treatment Study of Steroid Injection and Physical Therapy for Acute Lateral Epicondylitis

Lead Sponsor:

University of Oslo

Collaborating Sponsors:

Allmennmedisinsk forskningsfond, Norway

Conditions:

Tennis Elbow

Epicondylitis, Lateral Humeral

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to compare the clinical effect of physiotherapy alone or combined with corticosteroid injection in the initial treatment of lateral epicondylitis in a primary care setting...

Detailed Description

Much has been written about lateral epicondylitis/tennis elbow reflecting the existence of many treatments for the condition. However, there is no consensus as to which treatment gives the best result...

Eligibility Criteria

Inclusion

  • Age 18-70 years
  • Pain from the lateral part of the elbow
  • The pain increases on resisted dorsiflexion of the wrist with the elbow extended and the fingers flexed or the pain increases on resisted radial deviation of the wrist or the pain increases on resisted extension of the 3. finger

Exclusion

  • Duration of complaints less than 2 weeks or more than 3 months
  • The tenderness is located within the muscle body itself in the proximal part of the short radial extensors muscle of the wrist (Cyriax type IV)9.
  • Treatment within the last 12 months for the same condition with corticosteroid injection or physiotherapy
  • Bilateral complaints
  • Previous surgical treatment for lateral epicondylitis
  • Deformities of the elbow (congenital or acquired)
  • Cervical radiculopathy or referred pain from neck or shoulder
  • Previous fractures or tendon ruptures in the elbow
  • Systemic musculoskeletal disease
  • Previous allergic reactions to corticosteroids or lidocaine
  • Contraindications to corticosteroids or NSAIDs:
  • On-going or previous gastro-intestinal bleeding
  • previous ulcer or dyspepsia, severe asthma
  • on-going systemic infection
  • local skin-infection
  • recently vaccinated with live virus
  • coagulopathies
  • systemic lupus erythematodes
  • severe liver- or kidney-disease
  • heart failure
  • diabetes
  • use of warfarin or NSAIDS
  • Pregnancy or breast-feeding
  • Fertile females not on effective birth control
  • Psycho-social or other reasons for not being able to participate throughout the study.

Key Trial Info

Start Date :

March 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2013

Estimated Enrollment :

177 Patients enrolled

Trial Details

Trial ID

NCT00826462

Start Date

March 1 2009

End Date

June 1 2013

Last Update

January 24 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Grålum legesenter

Sarpsborg, Norway, 1712